| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Pediatrix Medical Group (NYSE:MD) reported its Q4 earnings results on Tuesday, February 20, 2024 at 06:00 AM.
Here's what investors need to know about the announcement.
Pediatrix Medical Group reported in-line EPS of $0.32 versus an estimate of $0.32.
Revenue was down $17.40 million from the same period last year.
Last quarter the company missed on EPS by $0.11 which was followed by a 0.1% increase in the share price the next day.
Here's a look at Pediatrix Medical Group's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.43 | 0.39 | 0.23 | 0.48 |
| EPS Actual | 0.32 | 0.39 | 0.23 | 0.47 |
| Revenue Estimate | 508.25M | 494.47M | 490.78M | 501.99M |
| Revenue Actual | 506.61M | 500.58M | 491.01M | 513.84M |
To track all earnings releases for Pediatrix Medical Group visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: MD
